otrivine tegen neusverstopping 0.5 mg/ml neusdruppels opl. druppelfl.
haleon belgium sa-nv - xylometazolinehydrochloride 0,05 g/100 ml - neusdruppels, oplossing - 0,5 mg/ml - xylometazolinehydrochloride 0.5 mg/ml - xylometazoline
otrivine sine conservans tegen neusverstopping 0.5 mg/ml neusspray opl. spuitbus
haleon belgium sa-nv - xylometazolinehydrochloride 0,05 g - neusspray, oplossing - 0,5 mg/ml - xylometazolinehydrochloride 0.5 mg/ml - xylometazoline
nexviadyme
sanofi b.v. - avalglucosidase alfa - glycogeen opslag ziekte type ii - andere maagdarmkanaal en metabolisme producten, - nexviadyme (avalglucosidase alfa) is indicated for long-term enzyme replacement therapy for the treatment of patients with pompe disease (acid α-glucosidase deficiency).
cresnisol n10 inf. opl. i.v.
baxter sa-nv - alanine 9,16 g/l; arginine 6,2 g/l; asparaginezuur 1,83 g/l; glutaminezuur 3,16 g/l; glycine 4,39 g/l; histidine 3,77 g/l; isoleucine 3,16 g/l; leucine 4,39 g/l; lysineacetaat 7,02 g/l - eq. lysine 4,98 g/l; methionine 3,16 g/l; fenylalanine 4,39 g/l; proline 3,77 g/l; serine 2,5 g/l; threonine 3,16 g/l; tryptofaan 1,06 g/l; tyrosine 0,16 g/l; valine 4,05 g/l - oplossing voor infusie - amino acids
nulibry
tmc pharma (eu) limited - fosdenopterin hydrobromide dihydrate - metal metabolism, inborn errors - andere maagdarmkanaal en metabolisme producten, - nulibry is indicated for the treatment of patients with molybdenum cofactor deficiency (mocd) type a.
pombiliti
amicus therapeutics europe limited - cipaglucosidase alfa - glycogeen opslag ziekte type ii - andere maagdarmkanaal en metabolisme producten, - pombiliti (cipaglucosidase alfa) is a long-term enzyme replacement therapy used in combination with the enzyme stabiliser miglustat for the treatment of adults with late-onset pompe disease (acid α-glucosidase [gaa] deficiency).
dzuveo
laboratoire aguettant - sufentanil citraat - pijn - anesthetica - dzuveo is indicated for the management of acute moderate to severe pain in adult patients.
actapulgite 3 g or. susp. (pdr.) sachet
ipsen sa-nv - attapulgiet 3 g - poeder voor suspensie voor oraal gebruik - 3 g - attapulgiet 3 g - attapulgite
targinact 30 mg - 15 mg tabl. verl. afgifte
mundipharma bv-srl - oxycodonhydrochloride 30 mg - eq. oxycodon 27 mg; naloxonhydrochloride 15 mg - eq. naloxon 13,5 mg - tablet met verlengde afgifte - 30 mg - 15 mg - oxycodonhydrochloride 30 mg; naloxonhydrochloride 15 mg - oxycodone, combinations
targinact 2,5 mg - 1,25 mg tabl. verl. afgifte
mundipharma bv-srl - oxycodonhydrochloride 2,5 mg - eq. oxycodon 2,25 mg; naloxonhydrochloride 1,25 mg - eq. naloxon 1,13 mg - tablet met verlengde afgifte - 2,5 mg - 1,25 mg - oxycodonhydrochloride 2.5 mg; naloxonhydrochloride 1.25 mg - oxycodone, combinations